Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer
Clinical trial NCT00095277 · COMPLETED
Trial details
- NCT number
- NCT00095277
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.